1. Home
  2. MMED vs CNS Comparison

MMED vs CNS Comparison

Compare MMED & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$14.91

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

N/A

Current Price

$73.75

Market Cap

3.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MMED
CNS
Founded
1983
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2026
2004

Fundamental Metrics

Financial Performance
Metric
MMED
CNS
Price
$14.91
$73.75
Analyst Decision
Strong Buy
Hold
Analyst Count
10
2
Target Price
$22.56
$71.50
AVG Volume (30 Days)
818.9K
200.1K
Earning Date
06-03-2026
04-16-2026
Dividend Yield
N/A
3.96%
EPS Growth
N/A
N/A
EPS
N/A
0.82
Revenue
N/A
$427,536,000.00
Revenue This Year
$15.99
$4.71
Revenue Next Year
$10.00
$4.37
P/E Ratio
N/A
$90.17
Revenue Growth
N/A
4.07
52 Week Low
$10.65
$58.39
52 Week High
$17.86
$78.81

Technical Indicators

Market Signals
Indicator
MMED
CNS
Relative Strength Index (RSI) 68.38 64.18
Support Level $10.68 $59.88
Resistance Level $15.80 $77.18
Average True Range (ATR) 0.88 1.85
MACD 0.49 0.11
Stochastic Oscillator 93.83 86.50

Price Performance

Historical Comparison
MMED
CNS

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two-thirds of its $98.4 billion in managed assets at the end of February. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.

Share on Social Networks: